iBio Inc (IBIO) Company Profile & Statistics

iBio Inc
IBIO
(AMEX)
Closed
2.64
+0.19 (+7.75%)
in:usd•As of: Nov 22, 2024 15:59 UTC -5
Open
2.45
High
2.80
Low
2.45

About iBio Inc

CEO

Martin Brenner

Headquarters

11750 sorrento valley road, suite 200

san diego, ca 92121, united states

Auditor

Grassi & Co., CPAs, P.C.

Employees

Share Holders

Website

www.ibioinc.com

Industry

pharmaceuticals other

Sector

health technology

Company Overview

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture of proteins applicable to a range of disease agents, such as influenza, sleeping sickness, anthrax, plague, human papillomavirus and veterinary influenza applications. IBio, Inc. is headquartered in Newark, Delaware.

iBio Inc Statistics

Valuation Measures

Market Capitalization ²	24.16M
Enterprise Value	14.53M
Enterprise Value/EBITDA (ttm)	-1.01
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.15
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	25.00%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-1111.14%
Return on Equity (ttm)	-78.53%
Return on Invested Capital (ttm)	-93.33%
Return on Assets (ttm)	-41.79%

Income Statement

Revenue (ttm)	175.00K
Revenue Per Share (ttm)	0.02
Gross Profit (ttm)	175.00K
EBITDA (ttm)³	-14.40M
Net Income Avi to Common (ttm)	-23.15M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	-3.33
52-Week Change	-49.23%
S&P500 52-Week Change	31.00%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	9.15M
Dividend Yield	0.00%
Float ⁴	9.10M
% Held by Insiders	0.58%
% Held by Institutions	7.90%

Balance Sheet

Total Cash (mrq)	11.04M
Total Cash Per Share (mrq)	1.21
Total Debt (mrq)	1.41M
Total Debt/Equity (mrq)	7.94%
Current Ratio (mrq)	3.37%
Quick Ratio (mrq)	3.37%
Book Value Per Share (mrq)	2.06

Cash Flow

Operating Cash Flow Per Share (ytd)	-0.43
Free Cash Flow (ytd)	-3.71M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

iBio Inc

Trade With A Regulated Broker